Opportunity Information: Apply for BJA 2020 17754
Apply for BJA 2020 17754
- The Department of Justice, Bureau of Justice Assistance in the health, humanities (see cultural affairs in cfda) sector is offering a public funding opportunity titled "BJA FY 20 Harold Rogers Prescription Drug Monitoring Program (PDMP)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 16.754.
- This funding opportunity was created on Mar 06, 2020.
- Applicants must submit their applications by May 05, 2020. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $2,000,000.00 in funding.
- The number of recipients for this funding is limited to 14 candidate(s).
- Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Others (see text field entitled Additional Information on Eligibility for clarification).
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The BJA FY 20 Harold Rogers Prescription Drug Monitoring Program (PDMP) grant is a discretionary funding opportunity from the U.S. Department of Justice, Bureau of Justice Assistance (BJA), designed to help jurisdictions detect, deter, and prevent the diversion and misuse of prescription controlled substances. PDMPs are statewide electronic databases that track dispensing of controlled medications and are commonly used to support clinical decision-making, identify potential doctor-shopping or unsafe prescribing patterns, and assist public safety and regulatory efforts aimed at reducing prescription drug abuse. The opportunity notes that PDMPs are already widely established nationwide, with 49 states and the U.S. territory of Guam operating PDMPs, so the program is aimed not only at starting systems where needed, but also at improving and strengthening existing ones.
A key feature of this program is flexibility for states and jurisdictions to plan, implement, or enhance PDMP capabilities in ways that align with local laws, governance structures, and policy preferences. In practice, this means applicants can tailor proposed activities to their own PDMP maturity level and local needs while still being encouraged to adopt and replicate promising practices that have shown results elsewhere. The overall goal is to make PDMPs more effective as a tool for reducing controlled-substance diversion and improving the ability of authorized users to identify problematic prescribing or dispensing patterns, thereby supporting both public health and public safety outcomes.
This grant opportunity (Funding Opportunity Number BJA-2020-17754; CFDA 16.754) provides awards up to an $2,000,000 ceiling, with an anticipated 14 awards. Eligible applicants include state governments as well as local government entities such as county governments, city or township governments, and special district governments, along with other eligible entities as described in the solicitation's additional eligibility guidance. The funding instrument is a grant, and the activity category is listed under health and humanities. The opportunity was created on March 6, 2020, and the original application closing date was May 5, 2020.
FAQs: BJA FY 20 Harold Rogers Prescription Drug Monitoring Program (PDMP) Grant
1) What is the BJA FY 20 Harold Rogers PDMP grant?
It is a discretionary funding opportunity from the U.S. Department of Justice, Bureau of Justice Assistance (BJA), intended to help jurisdictions detect, deter, and prevent the diversion and misuse of prescription controlled substances by supporting Prescription Drug Monitoring Programs (PDMPs).
2) What is a PDMP?
A PDMP is a statewide electronic database that tracks the dispensing of controlled medications. PDMP data is commonly used to support clinical decision-making, identify potential doctor-shopping or unsafe prescribing patterns, and assist public safety and regulatory efforts aimed at reducing prescription drug abuse.
3) What problem is this grant designed to address?
The grant is designed to reduce the diversion and misuse of prescription controlled substances by making PDMPs more effective and improving the ability of authorized users to identify problematic prescribing or dispensing patterns.
4) What are the main goals of the program?
The overall goals are to strengthen PDMPs as a tool for reducing controlled-substance diversion and to improve identification of problematic prescribing or dispensing patterns. These outcomes are intended to support both public health and public safety.
5) Is this program meant only for states that do not have a PDMP yet?
No. PDMPs are already widely established nationwide, with 49 states and the U.S. territory of Guam operating PDMPs. This program is aimed not only at starting systems where needed, but also at improving and strengthening existing PDMPs.
6) What kinds of PDMP activities can be supported with this funding?
The opportunity emphasizes flexibility for jurisdictions to plan, implement, or enhance PDMP capabilities in ways that align with local laws, governance structures, and policy preferences. Applicants can tailor activities to their PDMP maturity level and local needs, while being encouraged to adopt and replicate promising practices that have shown results elsewhere.
7) How flexible is the program for different jurisdictions?
A key feature is flexibility: states and jurisdictions may propose PDMP planning, implementation, or enhancement approaches that fit local laws, governance, and policy preferences. The intent is to allow applicants to match proposed work to their current PDMP maturity and local priorities.
8) What types of outcomes does BJA expect from PDMP improvements?
The opportunity describes outcomes such as better detection of doctor-shopping or unsafe prescribing patterns, improved support for clinical decision-making, and stronger public safety and regulatory efforts to reduce prescription drug abuse. The broader aim is improved public health and public safety outcomes.
9) Who is eligible to apply?
Eligible applicants include state governments and local government entities such as county governments, city or township governments, and special district governments. The solicitation also references additional eligibility guidance for other eligible entities.
10) Is this a formula program or discretionary funding?
This is a discretionary funding opportunity.
11) What agency is offering this grant?
The grant is offered by the U.S. Department of Justice, Bureau of Justice Assistance (BJA).
12) What is the Funding Opportunity Number for this solicitation?
The Funding Opportunity Number is BJA-2020-17754.
13) What is the CFDA number listed for this opportunity?
The CFDA number listed is 16.754.
14) What is the maximum award amount?
The award ceiling is up to $2,000,000.
15) How many awards are anticipated?
The opportunity anticipates approximately 14 awards.
16) What type of funding instrument is used?
The funding instrument is a grant.
17) What activity category is associated with this opportunity?
The activity category is listed under health and humanities.
18) When was this opportunity created?
The opportunity was created on March 6, 2020.
19) What was the original application closing date?
The original application closing date was May 5, 2020.
20) How do PDMPs support both public health and public safety?
PDMPs can help clinicians with decision-making and help identify potentially unsafe or suspicious patterns such as doctor-shopping. They can also support public safety and regulatory efforts aimed at reducing prescription drug abuse, which connects to both public health and public safety outcomes.
Browse more opportunities from the same category: Health, Humanities (see Cultural Affairs in CFDA)
Next opportunity: Ethnographic Overview and Assessment of Pinnacles National Park
Previous opportunity: Internet Freedom: Advancing and Promoting Peer-to-Peer Communications Technologies
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for BJA 2020 17754
[Watch] how do funding administrators access proposals?
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "BJA 2020 17754", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.